Eric Pineda

Eric Pineda Taparra Lab

Eric Pineda, BS

Chamorro

(He/Him/His)

Medical Student MS4-MBA

Tulane University

Cancer Disparities

Hafa Adai! I am an aspiring Otolaryngologist, passionate about understanding cancer health and disparities in Pacific Islander communities. My research interest include thyroid malignancies, data disaggregation, and social determinants of health research. 

Hometown: Yigo, Guam

Undergrad: BS, UC San Diego, Biochemistry and Cell Biology majors

Medical School: Tulane University School of Medicine

Contact: Linkedin, Twitter

Hobbies: Running, backpacking, traveling and trying new food, being an uncle

In June, our team published a study in JAMA Health Forum highlighting significant disparities in Phase 2/3 oncology clinical trial representation. The study found that while the majority of studies in 4 high-impact journals publish race/ethnicity data, only 14% of trials report on American Indian/Alaska Native (AI/AN) patients and 8% on Native Hawaiian/Other Pacific Islander (NHPI) patients. Relative to the US population with cancer, the representation quotients among these Indigenous groups were not just low, but zero. The results indicate a complete omission relative to their population with cancer. Congratulations to the team, including Ryan Benavente, Jonathan Shih, Megan Gimmen, Kā‘eo Kekumano, Eric Pineda, Paul Tominez, Giselle Halualani, and Henrietta Cakobau for bringing this important statistic to light. We are grateful for the major assistance from our incredible team of senior authors.
TwitterLinkedInLinkLink